Close

EBS Financial Facts

Contracts and grants: 31.5M
Total revenues: 142.91M
See Full Income Statement

Deferred tax assets, net: 11.29M
Inventories: 81.16M
See Full Balance Sheet

Emergent BioSolutions, Inc. (EBS) Earnings

  |   Expand Research on EBS
Next EPS Date 4/25/24 EPS Growth Rate +99.1%
Average EPS % Beat Rate -421.0% Revenue Growth Rate +12.3%
Average % Move 1-Wk after EPS -23.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/25/24 Q124 N/A-$0.03 N/A N/A$185.4M N/A N/A N/A
2/26/24 Q423 N/A$0.16 N/A N/A$282.16M = N/A N/A
2/22/24 Q423 N/A$0.16 N/A N/A$282.16M = N/A N/A
3/6/24 Q423 N/A$0.16 N/A N/A$282.16M = N/A N/A
11/2/23 Q323 N/A-$0.28 N/A N/A$237.43M = N/A N/A
11/8/23 Q323 N/A$0.00 N/A $271M$237.43M = N/A N/A
7/27/23 Q223 N/A-$0.69 N/A N/A$216.2M = N/A N/A
8/8/23 Q223 -$1.06-$0.63 -$0.43$337.9M$217.03M = Details